Trinity_ID	178	359	463	cluster	V2.x	uniprot_acc_ID	V4.x	V5.x	V6.x	V7.x	V8.x	V9.x	V10.x	V11.x	V12.x	V13	V14	V2.y	V3	V4.y	V5.y	V6.y	V7.y	V8.y	V9.y	V10.y	V11.y	V12.y
TRINITY_DN6902_c0_g1_i18	95	149	0	1	sp	B4N0P7	KRR1_DROWI	59.5	274	111	0	145	966	4	277	1.7e-93	346.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN186_c2_g1_i25	0	1291	5	1	sp	Q9Z2J0	S23A1_MOUSE	51.5	565	255	4	358	2013	35	593	1.7e-159	565.1	S23A1_MOUSE	reviewed	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	Slc23a1 Svct1 Yspl3	Mus musculus (Mouse)	605	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]	dehydroascorbic acid transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; sodium ion transmembrane transporter activity [GO:0015081]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	GO:0005737; GO:0005886; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904
TRINITY_DN2906_c0_g1_i15	310	259	0	2	sp	P54359	SEPT2_DROME	75.9	410	97	1	59	1288	12	419	4e-153	543.1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN769_c4_g1_i8	27	217	1	1	sp	Q3UUY6	PROM2_MOUSE	22.3	754	512	21	432	2597	97	808	5.2e-32	142.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2024_c13_g1_i1	42631	63403	102	1	sp	Q26061	FRI_PACLE	76.4	165	38	1	397	891	4	167	4.8e-69	263.8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN281_c1_g1_i8	4	31	0	1	sp	Q7SXW3	LRC40_DANRE	45.2	600	317	5	436	2223	8	599	1.4e-132	476.1	LRC40_DANRE	reviewed	Leucine-rich repeat-containing protein 40	lrrc40 zgc:63729	Danio rerio (Zebrafish) (Brachydanio rerio)	601	signal transduction [GO:0007165]	plasma membrane [GO:0005886]		plasma membrane [GO:0005886]; signal transduction [GO:0007165]	GO:0005886; GO:0007165
TRINITY_DN1055_c3_g1_i24	0	3	0	1	sp	Q96ST3	SIN3A_HUMAN	57.5	884	232	10	1211	3832	87	836	4.9e-220	766.9	SIN3A_HUMAN	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	1273	activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]	kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcriptional repressor complex [GO:0017053]; transcription factor complex [GO:0005667]	chromatin binding [GO:0003682]; protein complex binding [GO:0032403]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor activity [GO:0001106]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; protein complex binding [GO:0032403]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor activity [GO:0001106]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deacetylation [GO:0006476]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]	GO:0000122; GO:0000776; GO:0000976; GO:0001102; GO:0001103; GO:0001106; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006351; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0031937; GO:0032403; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678
TRINITY_DN4235_c1_g1_i1	6213	3584	0	2	sp	P21522	ROA1_SCHAM	68.7	182	56	1	186	731	8	188	2.9e-69	265	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN186_c2_g1_i12	50	122	50	1	sp	P54385	DHE3_DROME	75.3	543	119	2	142	1731	22	562	8.2e-246	851.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN4763_c0_g1_i3	53527	41363	0	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1080_c1_g1_i4	99	56	0	2	sp	E1C1R4	UBP47_CHICK	43.4	369	191	7	448	1542	1011	1365	6.1e-82	307.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN3138_c4_g1_i6	0	0	4	3	sp	Q23979	MY61F_DROME	55.8	1038	443	10	132	3230	9	1035	0	1113.6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN4115_c2_g1_i1	4606	2623	2	2	sp	Q9VTH4	SCLLA_DROME	33.7	104	65	2	822	1130	152	252	1.7e-07	58.9	SCLLA_DROME	reviewed	Protein scylla (Protein regulated in development and DNA damage response 2) (REDD-2)	scyl CG7590	Drosophila melanogaster (Fruit fly)	280	apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; head involution [GO:0008258]; multicellular organism reproduction [GO:0032504]; negative regulation of growth [GO:0045926]; negative regulation of signal transduction [GO:0009968]; regulation of TOR signaling [GO:0032006]; response to oxidative stress [GO:0006979]	GO:0005737; GO:0006915; GO:0006974; GO:0006979; GO:0008219; GO:0008258; GO:0009968; GO:0032006; GO:0032504; GO:0045926
TRINITY_DN1838_c0_g1_i1	433	3908	11	1	sp	Q9VEN1	FLNA_DROME	60.7	2223	839	12	157	6771	4	2209	0	2819.6	FLNA_DROME	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	cher cheerio sko CG3937	Drosophila melanogaster (Fruit fly)	2210	behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]	actin binding [GO:0003779]	actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495
TRINITY_DN23_c1_g1_i10	107	261	0	1	sp	P35559	IDE_RAT	55	964	431	2	334	3225	52	1012	0	1102	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1308_c4_g1_i22	0	3	1	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN22623_c0_g1_i10	66	95	56	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN3644_c0_g1_i1	178	14	1	4	sp	P05547	TNNI_ASTLP	58.9	112	46	0	360	695	74	185	6.6e-28	126.7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN43504_c0_g1_i5	3735	5378	1	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN5477_c0_g1_i1	86	2	0	4	sp	P06708	TNNC2_ASTLP	87.3	150	19	0	196	645	1	150	2.2e-68	260.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN12078_c3_g1_i7	144	6	0	4	sp	Q1RLK6	B3GN4_MOUSE	28.9	256	174	3	447	1193	90	344	8e-27	125.2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1968_c0_g1_i1	1355	2830	3	1	sp	Q16822	PCKGM_HUMAN	68.6	609	188	2	277	2103	35	640	2.7e-263	909.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN428_c0_g1_i6	864	835	0	2	sp	Q9P2E3	ZNFX1_HUMAN	32.2	2019	1092	42	913	6855	131	1911	7.1e-206	720.3	ZNFX1_HUMAN	reviewed	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	1918		nucleus [GO:0005634]	RNA binding [GO:0003723]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]	nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003723; GO:0005634; GO:0008270
TRINITY_DN15422_c0_g1_i21	141	15	0	4	sp	Q92879	CELF1_HUMAN	56.2	525	170	12	920	2458	10	486	8.4e-100	367.9	CELF1_HUMAN	reviewed	CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2)	CELF1 BRUNOL2 CUGBP CUGBP1 NAB50	Homo sapiens (Human)	486	embryo development [GO:0009790]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; regulation of RNA splicing [GO:0043484]; RNA interference [GO:0016246]	cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	BRE binding [GO:0042835]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity, nucleic acid binding [GO:0000900]	cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity, nucleic acid binding [GO:0000900]; embryo development [GO:0009790]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; regulation of RNA splicing [GO:0043484]; RNA interference [GO:0016246]	GO:0000900; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0007281; GO:0009790; GO:0016020; GO:0016246; GO:0030529; GO:0042835; GO:0043484
TRINITY_DN105280_c0_g1_i1	211	25	2	4	sp	P53777	MLP1_DROME	66.3	92	31	0	101	376	1	92	9.9e-31	136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN9515_c0_g1_i5	30	3	0	4	sp	P30163	ACT2_ONCVO	93.1	376	26	0	44	1171	1	376	3.3e-208	725.7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN9515_c0_g1_i24	17	2	0	4	sp	P30163	ACT2_ONCVO	93.1	376	26	0	44	1171	1	376	5.2e-208	724.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN269_c2_g2_i2	448	547	1	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN7420_c1_g1_i4	0	1	0	1	sp	Q9UPN3	MACF1_HUMAN	28.2	1954	1182	42	518	6055	74	1915	1e-201	706.8	MACF1_HUMAN	reviewed	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)	MACF1 ABP620 ACF7 KIAA0465 KIAA1251	Homo sapiens (Human)	7388	Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	GO:0003723; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0008017; GO:0010632; GO:0016055; GO:0016887; GO:0030177; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045296; GO:0045773; GO:0051015; GO:0051893
TRINITY_DN1688_c1_g1_i2	218	47	107	4	sp	O15514	RPB4_HUMAN	73	141	36	1	378	800	4	142	6.4e-47	189.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN10286_c0_g1_i1	200	433	0	1	sp	P17861	XBP1_HUMAN	66.7	57	18	1	422	589	48	104	2.6e-08	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN12600_c0_g1_i2	14	81	0	1	sp	Q8VHC8	MA2B1_CAVPO	48.1	1023	465	21	304	3336	34	1002	1.7e-252	874.4	MA2B1_CAVPO	reviewed	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)	MAN2B1 MANB	Cavia porcellus (Guinea pig)	1007	mannose metabolic process [GO:0006013]	lysosome [GO:0005764]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]	GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0046872
TRINITY_DN60570_c0_g1_i6	1400	595	0	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN19145_c0_g1_i6	76	116	0	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1736_c1_g1_i23	469	9	0	4	sp	O97159	CHDM_DROME	66.9	1939	510	19	542	6196	121	1982	0	1906	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN5929_c1_g1_i4	17	67	0	1	sp	Q9QX15	CA3A1_MOUSE	34.1	308	166	9	358	1218	24	315	1.4e-41	172.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2965_c1_g1_i12	374	4	0	4	sp	O97725	NDUAC_BOVIN	44.4	133	66	3	106	483	9	140	1.4e-26	121.7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN774_c5_g1_i1	130	1	62	4	sp	P56079	CDS_DROME	63.8	425	144	3	158	1426	26	442	7.1e-156	553.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN19749_c0_g1_i28	24	3139	0	1	sp	Q8JHW2	TSP3A_DANRE	56.6	675	273	8	1503	3491	281	947	1.3e-188	662.5	TSP3A_DANRE	reviewed	Thrombospondin-3a (Thbs3a)	thbs3a thbs3 tsp3 zgc:103461	Danio rerio (Zebrafish) (Brachydanio rerio)	962	cell adhesion [GO:0007155]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]	GO:0005509; GO:0005576; GO:0007155; GO:0008201
TRINITY_DN1091_c0_g1_i16	46	29	0	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2310_c0_g1_i2	1995	1156	39	2	sp	A1ZA47	ZASP_DROME	61.1	208	79	1	484	1101	1987	2194	4.6e-81	303.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN33269_c0_g1_i3	24	346	0	1	sp	Q9GKX6	GALM_PIG	45.8	354	178	8	294	1352	1	341	8e-83	310.1	GALM_PIG	reviewed	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GALM	Sus scrofa (Pig)	342	galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]	GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499; GO:0070062
TRINITY_DN276_c0_g1_i3	53	34	0	2	sp	Q8CGY8	OGT1_MOUSE	78.3	1021	208	4	270	3311	23	1036	0	1630.9	OGT1_MOUSE	reviewed	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	Ogt	Mus musculus (Mouse)	1046	apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein O-linked glycosylation [GO:0006493]; regulation of gluconeogenesis involved in cellular glucose homeostasis [GO:0090526]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; response to insulin [GO:0032868]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; N-acetyltransferase activity [GO:0008080]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; N-acetyltransferase activity [GO:0008080]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein O-linked glycosylation [GO:0006493]; regulation of gluconeogenesis involved in cellular glucose homeostasis [GO:0090526]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; response to insulin [GO:0032868]	GO:0000123; GO:0003824; GO:0005547; GO:0005622; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006110; GO:0006493; GO:0006915; GO:0008080; GO:0016262; GO:0031397; GO:0032868; GO:0032922; GO:0035020; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0045862; GO:0045944; GO:0046626; GO:0046972; GO:0048015; GO:0061087; GO:0080182; GO:0090526; GO:0097363
TRINITY_DN1536_c0_g1_i1	23	21	0	2	sp	Q3SYV4	CAP1_BOVIN	49.2	476	222	8	95	1489	3	469	2.6e-107	391.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN23_c2_g1_i9	320	458	0	1	sp	Q8BZ20	PAR12_MOUSE	25	585	331	18	18	1688	184	688	7e-38	160.6	PAR12_MOUSE	reviewed	Poly [ADP-ribose] polymerase 12 (PARP-12) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Zinc finger CCCH domain-containing protein 1)	Parp12 Zc3hdc1	Mus musculus (Mouse)	711		nucleus [GO:0005634]	metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723]	GO:0003723; GO:0003950; GO:0005634; GO:0046872
TRINITY_DN3766_c0_g1_i18	0	175	5	1	sp	Q9XYC2	RL15_FAXLI	95.2	146	7	0	339	776	59	204	9e-76	285	RL15_ORCLI	reviewed	60S ribosomal protein L15	RPL15	Orconectes limosus (Spinycheek crayfish) (Faxonius limosus)	204	translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	GO:0003735; GO:0005840; GO:0006412
TRINITY_DN3766_c0_g1_i18	0	175	5	1	sp	Q9XYC2	RL15_FAXLI	96.6	58	2	0	76	249	1	58	5.5e-25	116.3	RL15_ORCLI	reviewed	60S ribosomal protein L15	RPL15	Orconectes limosus (Spinycheek crayfish) (Faxonius limosus)	204	translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	GO:0003735; GO:0005840; GO:0006412
TRINITY_DN3766_c0_g1_i18	0	175	5	1	sp	Q9XYC2	RL15_FAXLI	92	25	2	0	263	337	1	25	1.7e-05	51.6	RL15_ORCLI	reviewed	60S ribosomal protein L15	RPL15	Orconectes limosus (Spinycheek crayfish) (Faxonius limosus)	204	translation [GO:0006412]	ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]	GO:0003735; GO:0005840; GO:0006412
TRINITY_DN63_c0_g1_i16	25	22	0	2	sp	P08630	BTKL_DROME	60	447	172	6	1464	2798	333	774	2.3e-151	538.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN3668_c0_g1_i7	0	0	17	3	sp	Q5T4S7	UBR4_HUMAN	51.9	3158	1319	38	621	9890	2157	5183	0	2784.2	UBR4_HUMAN	reviewed	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	5183	neutrophil degranulation [GO:0043312]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; viral process [GO:0016032]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; viral process [GO:0016032]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0042787; GO:0043312; GO:0070821; GO:0101003
TRINITY_DN868_c1_g2_i5	37	17	1	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN4867_c0_g2_i6	132	283	138	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN32526_c0_g1_i15	1263	6843	0	1	sp	P51023	PNT_DROME	81.7	115	15	1	1683	2027	590	698	3.5e-49	198	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN8902_c0_g1_i3	0	0	1	3	sp	Q3T0X5	PSA1_BOVIN	67.8	242	78	0	166	891	1	242	2e-91	337.8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN3136_c0_g2_i2	65	2355	23	1	sp	P86733	KCP_HALAI	38.2	136	57	2	1766	2173	13	121	2e-21	106.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN7420_c1_g1_i5	0	17	0	1	sp	Q9UPN3	MACF1_HUMAN	28.8	1921	1181	41	518	5956	74	1915	2.1e-207	725.7	MACF1_HUMAN	reviewed	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)	MACF1 ABP620 ACF7 KIAA0465 KIAA1251	Homo sapiens (Human)	7388	Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	GO:0003723; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0008017; GO:0010632; GO:0016055; GO:0016887; GO:0030177; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045296; GO:0045773; GO:0051015; GO:0051893
TRINITY_DN4988_c0_g1_i8	0	0	42	3	sp	Q96N67	DOCK7_HUMAN	51.9	2145	902	37	23	6187	4	2109	0	2013.8	DOCK7_HUMAN	reviewed	Dedicator of cytokinesis protein 7	DOCK7 KIAA1771	Homo sapiens (Human)	2140	activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; intracellular [GO:0005622]; neuron projection [GO:0043005]	guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; intracellular [GO:0005622]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	GO:0000226; GO:0005085; GO:0005622; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0033138; GO:0043005; GO:0045178; GO:0045200; GO:0048365; GO:0050767; GO:0090630; GO:1904754
TRINITY_DN4655_c0_g1_i16	9	40	17	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1308_c4_g1_i35	90	700	0	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN13131_c0_g1_i3	0	27	0	1	sp	Q9ULT8	HECD1_HUMAN	47.4	2135	793	34	144	6086	652	2610	0	1718.7	HECD1_HUMAN	reviewed	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)	HECTD1 KIAA1131	Homo sapiens (Human)	2610		cytoplasm [GO:0005737]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0046872; GO:0061630
TRINITY_DN1566_c1_g1_i12	0	8	0	1	sp	Q6PE18	P4K2A_DANRE	67.8	385	114	2	335	1483	70	446	1.1e-158	562.8	P4K2A_DANRE	reviewed	Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha)	pi4k2a pi4kii si:ch211-197k17.1	Danio rerio (Zebrafish) (Brachydanio rerio)	447	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; host cell presynaptic membrane [GO:0044231]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endosome [GO:0005768]; growing cell tip [GO:0035838]; host cell presynaptic membrane [GO:0044231]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	GO:0004430; GO:0005524; GO:0005739; GO:0005765; GO:0005768; GO:0005802; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0030054; GO:0030425; GO:0031224; GO:0031410; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0044231; GO:0045121; GO:0046854
TRINITY_DN1687_c0_g1_i4	2173	2125	2	2	sp	Q4R502	IDHP_MACFA	72.1	427	116	3	205	1479	24	449	2.3e-182	641	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN9214_c0_g1_i10	127	123	1	2	sp	Q5VT52	RPRD2_HUMAN	34.8	293	167	6	357	1169	21	311	5.2e-36	155.2	RPRD2_HUMAN	reviewed	Regulation of nuclear pre-mRNA domain-containing protein 2	RPRD2 KIAA0460 HSPC099	Homo sapiens (Human)	1461	snRNA transcription from RNA polymerase II promoter [GO:0042795]	DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]		DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]; snRNA transcription from RNA polymerase II promoter [GO:0042795]	GO:0005654; GO:0016591; GO:0042795
TRINITY_DN39893_c0_g1_i2	23	320	1	1	sp	O42161	ACTB_SALSA	90.7	108	10	0	1	324	268	375	1e-52	207.2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN4742_c0_g1_i7	50	4	1	4	sp	Q9VLQ1	ALG5_DROME	56	318	136	1	247	1200	11	324	1.1e-99	366.7	ALG5_DROME	reviewed	Dolichyl-phosphate beta-glucosyltransferase (EC 2.4.1.117) (Wollknaeuel)	wol alg5 CG7870	Drosophila melanogaster (Fruit fly)	326	chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; Golgi organization [GO:0007030]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; transferase activity [GO:0016740]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; transferase activity [GO:0016740]; chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; Golgi organization [GO:0007030]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]	GO:0004581; GO:0005783; GO:0005789; GO:0006487; GO:0006493; GO:0007009; GO:0007029; GO:0007030; GO:0007379; GO:0007509; GO:0009880; GO:0009953; GO:0010004; GO:0016021; GO:0016740; GO:0019991; GO:0040003
TRINITY_DN11178_c0_g1_i1	29	1	0	4	sp	A9X4T1	CHD1_BOMMO	60	1308	446	18	1321	5148	2	1264	0	1322.8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN5253_c0_g1_i6	0	3	0	1	sp	A1Z713	VPS13_DROME	31.9	3466	1979	66	137	9919	2	3292	0	1637.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1968_c0_g1_i3	300	1461	0	1	sp	Q16822	PCKGM_HUMAN	68.5	616	191	2	517	2364	28	640	2.1e-264	913.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN30357_c0_g2_i2	272	191	0	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1804_c1_g1_i20	2355	1293	1	2	sp	Q9YHV4	FSTA_DANRE	43.1	51	26	2	172	324	122	169	9.9e-05	48.9	FSTA_DANRE	reviewed	Follistatin-A (FS) (Activin-binding protein) (Follistatin-1) (zFst1)	fsta fst fst1 si:dkey-111k10.2 si:dkeyp-88a5.1	Danio rerio (Zebrafish) (Brachydanio rerio)	322	determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; midbrain development [GO:0030901]; oocyte differentiation [GO:0009994]; otic placode formation [GO:0043049]	extracellular region [GO:0005576]		extracellular region [GO:0005576]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; midbrain development [GO:0030901]; oocyte differentiation [GO:0009994]; otic placode formation [GO:0043049]	GO:0005576; GO:0009953; GO:0009994; GO:0030901; GO:0043049; GO:0048263; GO:0048703
TRINITY_DN4655_c0_g1_i15	45385	24387	27	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN12397_c1_g1_i1	0	3	0	1	sp	O75914	PAK3_HUMAN	79.1	321	66	1	10	969	236	556	1.5e-144	516.2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN10220_c0_g1_i3	914	698	0	2	sp	Q15637	SF01_HUMAN	65.8	319	98	4	418	1368	15	324	5.3e-117	424.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN8852_c2_g2_i1	440	378	29	2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN1255_c0_g1_i3	0	177	0	1	sp	Q6GVM6	DDX3Y_PANTR	71	483	108	4	652	2088	124	578	8.8e-192	672.9	DDX3Y_PANTR	reviewed	ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal)	DDX3Y	Pan troglodytes (Chimpanzee)	660	chromosome segregation [GO:0007059]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]; translational initiation [GO:0006413]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]; translational initiation [GO:0006413]	GO:0003677; GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0005829; GO:0006413; GO:0007059; GO:0010468; GO:0010501; GO:0016020; GO:0036464
TRINITY_DN4702_c0_g1_i2	0	0	2	3	sp	P09917	LOX5_HUMAN	26.7	688	466	14	231	2222	1	674	9.3e-70	267.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2167_c1_g1_i8	294	301	1257	3	sp	Q96PM5	ZN363_HUMAN	47.3	55	29	0	2093	1929	29	83	9.2e-11	70.5	ZN363_HUMAN	reviewed	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)	RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363	Homo sapiens (Human)	261	error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]	GO:0000151; GO:0002039; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042787; GO:0042803; GO:0051865; GO:0070987
TRINITY_DN34520_c0_g1_i5	0	81	0	1	sp	Q8VHG2	AMOT_MOUSE	38.3	376	214	6	1310	2416	411	775	8.5e-50	202.2	AMOT_MOUSE	reviewed	Angiomotin	Amot Kiaa1071	Mus musculus (Mouse)	1126	actin cytoskeleton organization [GO:0030036]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; stress fiber [GO:0001725]	angiostatin binding [GO:0043532]; receptor activity [GO:0004872]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; receptor activity [GO:0004872]; actin cytoskeleton organization [GO:0030036]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0004872; GO:0005737; GO:0005884; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056
TRINITY_DN691_c3_g1_i15	39	62	3	1	sp	Q90941	PB1_CHICK	32.1	1758	951	36	586	5595	22	1624	2.1e-233	812	PB1_CHICK	reviewed	Protein polybromo-1	PBRM1 PB1	Gallus gallus (Chicken)	1633	covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	GO:0003677; GO:0003682; GO:0005634; GO:0006351; GO:0006355; GO:0016569
TRINITY_DN48763_c1_g1_i1	5847	13418	6144	1	sp	B0FWD1	COX3_AEDAE	70	257	77	0	1786	2556	2	258	1e-99	366.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN17994_c1_g1_i4	0	0	1	3	sp	Q63054	ICA69_RAT	39	525	249	10	180	1739	7	465	6.5e-77	290	ICA69_RAT	reviewed	Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69)	Ica1	Rattus norvegicus (Rat)	480	neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of protein homodimerization activity [GO:0043496]	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]	protein domain specific binding [GO:0019904]	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of protein homodimerization activity [GO:0043496]	GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030054; GO:0030425; GO:0030667; GO:0030672; GO:0043496; GO:0048471; GO:0050796
TRINITY_DN1736_c1_g1_i1	19	701	0	1	sp	O97159	CHDM_DROME	66.2	1955	507	21	542	6226	121	1982	0	1894.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2216_c0_g1_i4	8	0	134	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN3778_c0_g1_i12	87	34	0	2	sp	P33175	KIF5A_MOUSE	59	939	360	7	633	3401	6	935	7.7e-268	925.6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN98711_c0_g1_i1	1893	1445	34	2	sp	O77245	E75_METEN	91.1	416	36	1	501	1748	103	517	6.6e-207	722.6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN17994_c1_g1_i8	61	89	6	1	sp	Q63054	ICA69_RAT	39	525	249	10	180	1739	7	465	6.5e-77	290	ICA69_RAT	reviewed	Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69)	Ica1	Rattus norvegicus (Rat)	480	neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of protein homodimerization activity [GO:0043496]	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]	protein domain specific binding [GO:0019904]	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of protein homodimerization activity [GO:0043496]	GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030054; GO:0030425; GO:0030667; GO:0030672; GO:0043496; GO:0048471; GO:0050796
TRINITY_DN4235_c1_g1_i7	7803	4564	0	2	sp	P21522	ROA1_SCHAM	68.7	182	56	1	174	719	8	188	2.9e-69	265	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN276_c2_g2_i8	0	213	0	1	sp	Q9DBY1	SYVN1_MOUSE	73.6	326	85	1	804	1778	10	335	1e-136	489.6	SYVN1_MOUSE	reviewed	E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1)	Syvn1 Hrd1 Kiaa1810	Mus musculus (Mouse)	612	endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; in utero embryonic development [GO:0001701]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein catabolic process [GO:0030163]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]	Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]; ubiquitin ligase complex [GO:0000151]	ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]	Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]; ubiquitin ligase complex [GO:0000151]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; in utero embryonic development [GO:0001701]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein catabolic process [GO:0030163]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]	GO:0000151; GO:0000209; GO:0000836; GO:0000839; GO:0001701; GO:0005654; GO:0005783; GO:0005790; GO:0006986; GO:0016020; GO:0016021; GO:0016567; GO:0018279; GO:0030163; GO:0030433; GO:0030968; GO:0030970; GO:0036503; GO:0036513; GO:0042787; GO:0044322; GO:0046872; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:1902236; GO:1904264; GO:1990381
TRINITY_DN15422_c0_g1_i4	94	148	0	1	sp	O95319	CELF2_HUMAN	55.2	533	170	11	920	2485	34	508	5.5e-99	365.2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN15508_c0_g1_i3	38	106	26	1	sp	Q14586	ZN267_HUMAN	35.4	260	157	7	264	1034	487	738	6.1e-40	167.5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN34022_c0_g1_i2	175	8	19	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN213_c0_g1_i2	0	93	0	1	sp	P41900	T2FB_DROME	53.3	259	112	3	148	897	13	271	9.2e-73	276.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2708_c0_g1_i2	378	40	18	4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN186_c2_g1_i3	124	1689	0	1	sp	P48375	FKB12_DROME	75	108	27	0	163	486	1	108	6.4e-44	181.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRINITY_DN2789_c0_g3_i2	0	542	4	1	sp	Q5FYA8	ARSH_HUMAN	39.9	561	304	10	430	2091	7	541	3.2e-98	361.3	ARSH_HUMAN	reviewed	Arylsulfatase H (ASH) (EC 3.1.6.-)	ARSH	Homo sapiens (Human)	562	glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]	GO:0004065; GO:0005788; GO:0006687; GO:0016021; GO:0043687; GO:0046872
TRINITY_DN27990_c0_g1_i5	0	132	0	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
